dacarbazine has been researched along with Craniopharyngioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboukais, R; Assaker, R; Maurage, CA; Zairi, F | 1 |
| Altuntaş, Y; Aydın, Y; Karaman, O; Müslüman, AM; Ozderya, A; Ozkayalar, H; Oztürk, FY; Tanık, C; Zuhur, SS | 1 |
2 other study(ies) available for dacarbazine and Craniopharyngioma
| Article | Year |
|---|---|
Glioblastoma occurring after the surgical resection of a craniopharyngioma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Protocols; Craniopharyngioma; Dacarbazine; Glioblastoma; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Pituitary Neoplasms; Temozolomide; Tomography, X-Ray Computed | 2014 |
MGMT immunoexpression in adamantinomatous craniopharyngiomas.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor; Child; Child, Preschool; Craniopharyngioma; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary Neoplasms; Prognosis; Temozolomide; Tumor Suppressor Proteins; Young Adult | 2011 |